Roivant Sciences Overview
Roivant Sciences Target Price
Analysts' 12-month price predictions for ROIV.
Get informed when a big investor buys or sells
+ FollowShare Price
$32.21
Average Target Price
$38.60
19.8% upside
19.8% upside5 analysts in the last 4 months
High: $42 | Low: $34
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-26 | GuggenheimYastin Suneja | $36 | 11.8% upside |  |
| 2026-05-21 | Cowen & Co. | $41 | 27.3% upside | |
| 2026-05-21 | Leerink PartnersDavid Risinger | $42 | 30.4% upside | |
| 2026-04-16 | Piper Sandler | $40 | 24.2% upside | |
| 2026-03-04 | H.C. WainwrightDouglas Tsao | $34 | 5.6% upside | |
| 2026-02-10 | H.C. Wainwright | $33 | 2.5% upside | |
| 2026-02-09 | Jefferies | $30 |  6.9% downside | |
| 2026-02-09 | Guggenheim | $30 | 6.9% downside | |
| 2025-12-18 | Guggenheim | $28 | 13.1% downside | |
| 2025-12-15 | Leerink PartnersDavid Risinger | $32 | 0.7% downside | |
| 2025-12-12 | H.C. Wainwright | $26 | 19.3% downside | |
| 2025-11-14 | GuggenheimYastin Suneja | $25 | 22.4% downside | |
| 2025-11-11 | Leerink PartnersDavid Risinger | $29 | 10% downside | |
| 2025-09-18 | Jefferies | $20 | 37.9% downside | |
| 2025-09-18 | Guggenheim | $21 | 34.8% downside | |
| 2025-09-18 | H.C. Wainwright | $20 | 37.9% downside | |
| 2024-10-21 | Leerink PartnersDavid Risinger | $17 | 47.2% downside | |
| 2024-09-19 | Goldman SachsCorinne Jenkins | $17 | 47.2% downside | |
| 2024-09-11 | Bank of America SecuritiesChi Fong | $12.5 | 61.2% downside | |
| 2024-05-31 | Piper SandlerAllison Bratzel | $20 | 37.9% downside | |
| 2024-04-03 | H.C. WainwrightDouglas Tsao | $18 | 44.1% downside | |
| 2024-04-03 | Deutsche BankNeena Bitritto-Garg | $15 | 53.4% downside | |
| 2024-04-02 | Goldman SachsCorinne Jenkins | $18 | 44.1% downside | |
| 2024-03-13 | Goldman SachsCorinne Jenkins | $16 | 50.3% downside | |
| 2023-01-05 | Citigroup | $14 | 56.5% downside | |
| 2022-12-19 | Leerink Partners | $10 | 69% downside | |
| 2022-08-18 | Citigroup | $10 | 69% downside | |
| 2022-05-24 | Goldman Sachs | $12 | 62.7% downside | |